Hisamitsu Pharmaceutical Co., Inc. / Fundamentals
Income statement
- Net revenue
€856.11M - Cost of goods sold
€373.46M - Gross profit
€482.65M - SG&A expenses
€334.93M - R&D expenses
€53.39M - EBITDA
€126.71M - D&A
€32.37M - EBIT
€94.33M - Interest expenses
€90.32K - EBT
€120.86M - Tax expenses
€30.40M - Net income
€87.67M
Cash flow statement
- Net deferred tax
€0.00 - Non-cash items
-€32.37M - Changes in working capital
€0.00 - Operating cash flow
€87.67M - Capex
€0.00 - Other investing cash flow
€0.00 - Net investing cash flow
€0.00 - Total cash dividends paid
€0.00 - Issuance of common stock
€0.00 - Debt repayment
€0.00 - Other financing cash flow
€0.00 - Net financing cash flow
€0.00 - Foreign exchange effects
€0.00 - Net change in cash
-€178.86M - Cash at end of period
€645.04M - Free cash flow
€87.67M
Balance sheet
- Cash and cash equivalents
€645.04M - Cash and short-term investments
€719.16M - Total receivables
€0.00 - Inventory
€125.40M - Other current assets
€46.90B - Total current assets
€1.16B - Property, plant & equipment
€296.14M - Goodwill
€26.98M - Intangible assets
€32.30M - Long-term investments
€392.43M - Other non-current assets
€61.05M - Total non-current assets
€781.93M - Total assets
€1.94B - Accounts payable
€8.62B - Short-term debt
€918.92M - Other current liabilities
-€9.26B - Total current liabilities
€292.20M - Long-term debt
€551.36K - Deferred tax liabilities
€0.00 - Other non-current liabilities
€75.27M - Total non-current liabilities
€75.83M - Total liabilities
€368.02M - Common stock
€49.18M - Retained earnings
€1.40B - Other equity
€284.89M - Total equity
€1.58B - Total liabilities and shareholders' equity
€1.94B
Company information
- Market capitalization
€1.76B - Employees
2.8K - Enterprise Value
€1.50B
Company ratios
- Gross margin
-
56.4% Worse than peer group: 69.1% - EBITDA margin
-
14.8% Worse than peer group: 23.9% - EBIT margin
-
11.0% Worse than peer group: 19.1% - EBT margin
-
14.1% Worse than peer group: 21.0% - Net margin
-
10.2% Even with peer group: 14.6% - ROE
-
5.6% Even with peer group: 6.7% - ROA
-
4.5% Even with peer group: 6.8% - Asset turnover
-
44.0% Even with peer group: 46.3% - FCF margin
-
10.2% Even with peer group: 9.2% - FCF yield
5.0% - Efficiency ratio
85.2% - Net sales per employee
-
€310.30K - Net income per employee
-
€31.78K